El día 15 de Noviembre comienza en Chicago el congreso de la AHA 2014. Tal y como hemos hecho en otras ocasiones, comentaremos en el blog los resultados de los Late-Breaking Clinical Trials.
En concreto, nos centraremos en las sesiones siguientes:
DOMINGO, 16 NOVIEMBRE 2014
LBCT.01 – Risk and Benefit of Dual Antiplatelet Therapy
Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent
Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint
Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study
LUNES, 17 NOVIEMBRE 2014
LBCT.02 – Anti-Lipid Therapy and Prevention of CAD
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Randomized Controlled Trial
ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm
IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
MARTES, 18 NOVIEMBRE 2014
LBCT.03 – Treatment of Structural Heart Disease
Randomized Trial of Atenolol Versus Losartan in Children and Young Adults With Marfan Syndrome
A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy – The INHERIT Trial
The Incidence of Infective Endocarditis in England is Increasing – An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics
The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network
MIERCOLES, 19 NOVIEMBRE 2014
LBCT.04 – Ischemic Heart Disease: Drugs, Devices and Systems of Care
Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial
Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
A Randomised Controlled Trial of Oxygen Therapy in Acute St-segment Elevation Myocardial Infarction: The Air Versus Oxygen in Myocardial Infarction (AVOID) Study
Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study
